To investigate the role of CDC25B–PP2A on metformin response in patients’ relevant model, we grew organoids from primary triple negative breast cancer patients’ derived xenograft (PDX) tumors (33). This evidence concerns the gene CDC25B and triple-negative breast carcinoma.